85 related articles for article (PubMed ID: 29618011)
1. Effects of Diazoxide-Mediated Insulin Suppression on Glucose and Lipid Metabolism in Nondiabetic Obese Men.
Loves S; van Groningen L; Filius M; Mekking M; Brandon T; Tack CJ; Hermus A; de Boer H
J Clin Endocrinol Metab; 2018 Jun; 103(6):2346-2353. PubMed ID: 29618011
[TBL] [Abstract][Full Text] [Related]
2. High-Dose, Diazoxide-Mediated Insulin Suppression Boosts Weight Loss Induced by Lifestyle Intervention.
Loves S; van Groningen L; Filius M; Mekking M; Brandon T; Tack CJ; Hermus A; de Boer H
J Clin Endocrinol Metab; 2018 Nov; 103(11):4014-4022. PubMed ID: 30202851
[TBL] [Abstract][Full Text] [Related]
3. Diazoxide-mediated insulin suppression in obese men: a dose-response study.
Schreuder T; Karreman M; Rennings A; Ruinemans-Koerts J; Jansen M; de Boer H
Diabetes Obes Metab; 2005 May; 7(3):239-45. PubMed ID: 15811140
[TBL] [Abstract][Full Text] [Related]
4. Weight loss in obese men by caloric restriction and high-dose diazoxide-mediated insulin suppression.
van Boekel G; Loves S; van Sorge A; Ruinemans-Koerts J; Rijnders T; de Boer H
Diabetes Obes Metab; 2008 Dec; 10(12):1195-203. PubMed ID: 18476985
[TBL] [Abstract][Full Text] [Related]
5. Diazoxide enhances basal metabolic rate and fat oxidation in obese Zucker rats.
Alemzadeh R; Karlstad MD; Tushaus K; Buchholz M
Metabolism; 2008 Nov; 57(11):1597-607. PubMed ID: 18940400
[TBL] [Abstract][Full Text] [Related]
6. Diazoxide in Children With Obesity After Hypothalamic-Pituitary Lesions: A Randomized, Placebo-Controlled Trial.
Brauner R; Serreau R; Souberbielle JC; Pouillot M; Grouazel S; Recasens C; Zerah M; Sainte-Rose C; Treluyer JM
J Clin Endocrinol Metab; 2016 Dec; 101(12):4825-4833. PubMed ID: 27603903
[TBL] [Abstract][Full Text] [Related]
7. Calcium plus vitamin D supplementation affects glucose metabolism and lipid concentrations in overweight and obese vitamin D deficient women with polycystic ovary syndrome.
Asemi Z; Foroozanfard F; Hashemi T; Bahmani F; Jamilian M; Esmaillzadeh A
Clin Nutr; 2015 Aug; 34(4):586-92. PubMed ID: 25300649
[TBL] [Abstract][Full Text] [Related]
8. Individualized Exercise Training at Maximal Fat Oxidation Combined with Fruit and Vegetable-Rich Diet in Overweight or Obese Women: The LIPOXmax-Réunion Randomized Controlled Trial.
Besnier F; Lenclume V; Gérardin P; Fianu A; Martinez J; Naty N; Porcherat S; Boussaid K; Schneebeli S; Jarlet E; Hatia S; Dalleau G; Verkindt C; Brun JF; Gonthier MP; Favier F
PLoS One; 2015; 10(11):e0139246. PubMed ID: 26555595
[TBL] [Abstract][Full Text] [Related]
9. Influence of short-term dexfenfluramine therapy on glucose and lipid metabolism in obese non-diabetic patients.
Andersen PH; Richelsen B; Bak J; Schmitz O; Sørensen NS; Lavielle R; Pedersen O
Acta Endocrinol (Copenh); 1993 Mar; 128(3):251-8. PubMed ID: 8480475
[TBL] [Abstract][Full Text] [Related]
10. Suppression of hyperinsulinemia restores growth hormone secretion and metabolism in obese mice.
Huang Z; Lu X; Huang L; Chen Y; Zhang C; Veldhuis JD; Chen C
J Endocrinol; 2021 Jul; 250(3):105-116. PubMed ID: 34156345
[TBL] [Abstract][Full Text] [Related]
11. [Effects of sibutramine on blood glucose and lipids, body fat mass and insulin resistance in obese patients: a multi-center clinical trial].
Tong NW; Ran XW; Li QF; Tang BD; Li R; Yang FY; Liu YP; Li XJ
Zhonghua Nei Ke Za Zhi; 2005 Sep; 44(9):659-63. PubMed ID: 16202254
[TBL] [Abstract][Full Text] [Related]
12. No effect of inhibition of insulin secretion by diazoxide on weight loss in hyperinsulinaemic obese subjects during an 8-week weight-loss diet.
Due A; Flint A; Eriksen G; Møller B; Raben A; Hansen JB; Astrup A
Diabetes Obes Metab; 2007 Jul; 9(4):566-74. PubMed ID: 17587399
[TBL] [Abstract][Full Text] [Related]
13. Low-dose growth hormone treatment with diet restriction accelerates body fat loss, exerts anabolic effect and improves growth hormone secretory dysfunction in obese adults.
Kim KR; Nam SY; Song YD; Lim SK; Lee HC; Huh KB
Horm Res; 1999; 51(2):78-84. PubMed ID: 10352397
[TBL] [Abstract][Full Text] [Related]
14. Short-term treatment with low doses of recombinant human GH stimulates lipolysis in visceral obese men.
Lucidi P; Parlanti N; Piccioni F; Santeusanio F; De Feo P
J Clin Endocrinol Metab; 2002 Jul; 87(7):3105-9. PubMed ID: 12107208
[TBL] [Abstract][Full Text] [Related]
15. Metabolic Effects of Long-Term Reduction in Free Fatty Acids With Acipimox in Obesity: A Randomized Trial.
Makimura H; Stanley TL; Suresh C; De Sousa-Coelho AL; Frontera WR; Syu S; Braun LR; Looby SE; Feldpausch MN; Torriani M; Lee H; Patti ME; Grinspoon SK
J Clin Endocrinol Metab; 2016 Mar; 101(3):1123-33. PubMed ID: 26691888
[TBL] [Abstract][Full Text] [Related]
16. Beneficial effect of diazoxide in obese hyperinsulinemic adults.
Alemzadeh R; Langley G; Upchurch L; Smith P; Slonim AE
J Clin Endocrinol Metab; 1998 Jun; 83(6):1911-5. PubMed ID: 9626118
[TBL] [Abstract][Full Text] [Related]
17. The effect of telmisartan on glucose and lipid metabolism in nondiabetic, insulin-resistant subjects.
Nagel JM; Tietz AB; Göke B; Parhofer KG
Metabolism; 2006 Sep; 55(9):1149-54. PubMed ID: 16919531
[TBL] [Abstract][Full Text] [Related]
18. [Pharmacological therapy of obesity].
Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
[TBL] [Abstract][Full Text] [Related]
19. Recombinant variant of ciliary neurotrophic factor for weight loss in obese adults: a randomized, dose-ranging study.
Ettinger MP; Littlejohn TW; Schwartz SL; Weiss SR; McIlwain HH; Heymsfield SB; Bray GA; Roberts WG; Heyman ER; Stambler N; Heshka S; Vicary C; Guler HP
JAMA; 2003 Apr; 289(14):1826-32. PubMed ID: 12684362
[TBL] [Abstract][Full Text] [Related]
20. Weight reduction versus antihypertensive drug therapy in obese men with high blood pressure: effects upon plasma insulin levels and association with changes in blood pressure and serum lipids.
Fagerberg B; Berglund A; Andersson OK; Berglund G
J Hypertens; 1992 Sep; 10(9):1053-61. PubMed ID: 1328365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
